Glibenclamide Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 1.25 mg, 2.5 mg, 5 mg

Reference Brands: Diabeta (USA), Euglucon (EU)

Category: Diabetes

Glibenclamide stimulates insulin secretion by binding to pancreatic β-cell sulfonylurea receptors, closing potassium channels, and triggering calcium influx. This enhances insulin release and reduces blood glucose levels. It effectively manages type 2 diabetes, especially in patients unresponsive to lifestyle changes alone, offering improved glycemic control and reduced hyperglycemic episodes. Glibenclamide Tablets is available in Tablets and strengths such as 1.25 mg, 2.5 mg, 5 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Glibenclamide Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Glibenclamide Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Glibenclamide tablets, also known as glyburide in the USA, are approved for the management of type 2 diabetes mellitus. In the USA, Glibenclamide is regulated under FDA-approved monographs and primarily marketed under brands like Diabeta and Micronase. In the EU, it is authorized through national procedures and widely available under brands such as Euglucon and generics from Sandoz and Teva. Due to the increased risk of hypoglycemia, especially in elderly patients, usage guidelines emphasize dose titration and caution in renal or hepatic impairment. Pharmatradz.com facilitates B2B sourcing of Glibenclamide across regulated markets.